We recently published a list of Jim Cramer’s Latest Stock Moves: Top 10 Calls. In this article, we are going to take a look ...

That said, one stock that continues to stand out is Johnson & Johnson JNJ. The pharmaceutical giant's stock hit new 52-week ...

Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to ...

JOHNSON & JOHNSON (JNJ) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 75% based on the firm’s underlying fundamentals and the stock’s ...

智通财经APP获悉，2025年3月17日，强生 (JNJ.US)在Clinicaltrials.gov网站上注册了IL-23R口服环肽抑制剂JNJ-2113 (Icotrokinra)治疗银屑病关节炎的三期临床试验ICONIC-PsA 1。该三期临床试验计划入组540例银屑病关节炎患者，预计2026年初步完成。

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...